Steroid bill gains strength
This article was originally published in The Tan Sheet
Executive Summary
Senate passes Anabolic Steroid Control Act of 2004 (S 2195) by unanimous consent Oct. 6. The bill, which makes a number of steroid precursors controlled substances, will now head to conference; the House passed a similar measure in June (1"The Tan Sheet" June 7, 2004, p. 13). The bill was stripped of a provision sought by Sen. Richard Durbin (D-Ill.) in September that would have required mandatory adverse event reporting in the Senate judiciary committee (2"The Tan Sheet" Oct. 4, 2004, In Brief)...
You may also be interested in...
Anabolic Steroid Act Heads To Senate After Clearing House 408-3
The Anabolic Steroid Control Act was sent to the Senate June 3 after passing the House with its exemption for dehydroepiandrosterone intact
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.